Shi Jian-pin
Abstract
Atrial fibrillation(AF)is a strong risk factor for ischemic cerebral stroke.Some inherent defects of Warfarin limit its clinic application,which accelerates research and development of new oral anticoagulants,such as Dabigatran,Apixaban,Rivaroxaban and Edoxaban etc..This article made an overview for these.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Atrial fibrillation(AF)is a strong risk factor for ischemic cerebral stroke.Some inherent defects of Warfarin limit its clinic application,which accelerates research and development of new oral anticoagulants,such as Dabigatran,Apixaban,Rivaroxaban and Edoxaban etc..This article made an overview for these.
Key concepts: Edoxaban, Medicine, Apixaban, Rivaroxaban, Dabigatran, Atrial fibrillation, Warfarin, Stroke (engine)